Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2026
Piramal Pharma completes acquisition of controlling stake in Yapan Bio
Piramal Pharma Ltd. completed the acquisition of an incremental 40.67% stake in Yapan Bio Private Limited for an aggregate cash consideration of ₹76 crore ($7.95M USD), bringing its ownership to 74% and making Yapan Bio a subsidiary.
2021
Piramal Pharma acquires Hemmo Pharmaceuticals
Piramal Pharma Limited's Contract Development and Manufacturing Organization, Piramal Pharma Solutions, fully acquired Hemmo Pharmaceuticals for Rs 775 crore.
2020
Piramal Pharma Solutions announces agreement to acquire Sellersville facility
Piramal Pharma Solutions announced an agreement to acquire G&W Laboratories' solid oral dosage drug product manufacturing facility in Sellersville, Pennsylvania. Closing is subject to customary pre-closing conditions.
2019
Piramal Pharma Solutions to partner with BerGenBio on bemcentinib development
Piramal Pharma Solutions announced that it will partner with Norway-based BerGenBio ASA on development of bemcentinib for elderly patients with relapsed Acute Myeloid Leukemia. The announced program includes development and manufacturing activities across India, North America, and Europe.